S&P 500   5,123.41
DOW   37,983.24
QQQ   441.24
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks
S&P 500   5,123.41
DOW   37,983.24
QQQ   441.24
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks
S&P 500   5,123.41
DOW   37,983.24
QQQ   441.24
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks
S&P 500   5,123.41
DOW   37,983.24
QQQ   441.24
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks

Zynex (ZYXI) Competitors

$11.91
-0.23 (-1.89%)
(As of 04/12/2024 06:55 PM ET)

ZYXI vs. AXGN, EDAP, SMLR, OM, FONR, VANI, CUTR, BLFS, SLNO, and SRDX

Should you be buying Zynex stock or one of its competitors? The main competitors of Zynex include AxoGen (AXGN), Edap Tms (EDAP), Semler Scientific (SMLR), Outset Medical (OM), FONAR (FONR), Vivani Medical (VANI), Cutera (CUTR), BioLife Solutions (BLFS), Soleno Therapeutics (SLNO), and Surmodics (SRDX).

Zynex vs.

AxoGen (NASDAQ:AXGN) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

Zynex has a net margin of 5.28% compared to Zynex's net margin of -13.66%. AxoGen's return on equity of 16.82% beat Zynex's return on equity.

Company Net Margins Return on Equity Return on Assets
AxoGen-13.66% -22.38% -11.24%
Zynex 5.28%16.82%7.05%

AxoGen received 424 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 72.59% of users gave AxoGen an outperform vote while only 50.00% of users gave Zynex an outperform vote.

CompanyUnderperformOutperform
AxoGenOutperform Votes
445
72.59%
Underperform Votes
168
27.41%
ZynexOutperform Votes
21
50.00%
Underperform Votes
21
50.00%

In the previous week, AxoGen had 1 more articles in the media than Zynex. MarketBeat recorded 2 mentions for AxoGen and 1 mentions for Zynex. AxoGen's average media sentiment score of 1.89 beat Zynex's score of 1.47 indicating that Zynex is being referred to more favorably in the news media.

Company Overall Sentiment
AxoGen Positive
Zynex Very Positive

80.3% of AxoGen shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 7.2% of AxoGen shares are held by insiders. Comparatively, 46.6% of Zynex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Zynex has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AxoGen$159.01M1.98-$21.72M-$0.52-13.87
Zynex$184.32M2.08$9.73M$0.2744.11

AxoGen presently has a consensus target price of $10.67, indicating a potential upside of 47.94%. Zynex has a consensus target price of $18.00, indicating a potential upside of 51.13%. Given AxoGen's higher possible upside, analysts clearly believe Zynex is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AxoGen
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Zynex
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

AxoGen has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500.

Summary

Zynex beats AxoGen on 11 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZYXI vs. The Competition

MetricZynexElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$383.14M$3.16B$5.05B$7.65B
Dividend YieldN/A1.78%2.95%3.94%
P/E Ratio44.1114.11234.0118.65
Price / Sales2.0859.512,421.03103.05
Price / Cash28.9453.7436.8630.98
Price / Book8.764.384.604.29
Net Income$9.73M$87.71M$105.33M$214.57M
7 Day Performance-3.64%0.62%-2.30%-2.30%
1 Month Performance-2.30%11.03%-0.32%-0.06%
1 Year Performance-0.25%10.89%14.55%8.81%

Zynex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AXGN
AxoGen
2.5876 of 5 stars
$8.03
+1.4%
$10.67
+32.8%
-28.0%$350.83M$159.01M-15.44426Positive News
EDAP
Edap Tms
3.001 of 5 stars
$8.50
+1.9%
$14.67
+72.5%
-29.0%$313.74M$65.42M-13.49264Short Interest ↓
Positive News
SMLR
Semler Scientific
0 of 5 stars
$29.30
+4.2%
N/A+13.5%$205.98M$68.18M11.1092
OM
Outset Medical
1.7819 of 5 stars
$2.51
-0.8%
$5.42
+115.8%
-88.6%$126.78M$130.38M-0.72480
FONR
FONAR
0 of 5 stars
$19.10
+1.9%
N/A+5.0%$120.87M$102.42M10.38561Short Interest ↓
News Coverage
VANI
Vivani Medical
0 of 5 stars
$2.05
-6.0%
N/A+105.0%$112.71MN/A-4.1050
CUTR
Cutera
1.2032 of 5 stars
$1.61
+5.2%
$14.75
+816.1%
-90.1%$32.11M$230.18M-0.22540Gap Up
BLFS
BioLife Solutions
1.6996 of 5 stars
$18.16
+4.9%
$23.40
+28.9%
-17.0%$784.14M$143.27M-11.95409Short Interest ↑
SLNO
Soleno Therapeutics
4.1583 of 5 stars
$41.09
+1.9%
$55.60
+35.3%
+1,049.8%$1.33BN/A-13.8433
SRDX
Surmodics
4.2928 of 5 stars
$27.75
+0.9%
$59.00
+112.6%
+14.7%$395.16M$132.58M73.03376Positive News

Related Companies and Tools

This page (NASDAQ:ZYXI) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners